Zobrazeno 1 - 10
of 243
pro vyhledávání: '"Gómez-España A"'
Autor:
María Victoria García-Ortiz, Pablo Cano-Ramírez, Marta Toledano-Fonseca, María Teresa Cano, Elizabeth Inga-Saavedra, Rosa María Rodríguez-Alonso, Silvia Guil-Luna, María Auxiliadora Gómez-España, Antonio Rodríguez-Ariza, Enrique Aranda
Publikováno v:
Clinical Epigenetics, Vol 15, Iss 1, Pp 1-15 (2023)
Abstract Background Pancreatic cancer is the most lethal cancer with a dismal prognosis mainly due to diagnosis at advanced stage and ineffective treatments. CA19-9 levels and computed tomography (CT) imaging are the main standard criteria for evalua
Externí odkaz:
https://doaj.org/article/e442b4ca5a724ef38f833fa78d27c3c6
Autor:
Silvia Guil-Luna, Aurora Rivas-Crespo, Carmen Navarrete-Sirvent, Ana Mantrana, Alejandra Pera, Rafael Mena-Osuna, Marta Toledano-Fonseca, María Victoria García-Ortíz, Carlos Villar, Maria Teresa Sánchez-Montero, Janna Krueger, Francisco Javier Medina-Fernández, Juan De La Haba-Rodríguez, Auxiliadora Gómez-España, Enrique Aranda, Christopher E. Rudd, Antonio Rodríguez-Ariza
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 167, Iss , Pp 115592- (2023)
Introduction: Glycogen synthase kinase 3 (GSK-3) has been proposed as a novel cancer target due to its regulating role in both tumor and immune cells. However, the connection between GSK-3 and immunoevasive contexture, including tumor budding (TB) ha
Externí odkaz:
https://doaj.org/article/77ecc79605674de6b8a6c57e14222455
Autor:
Guil-Luna, Silvia, Rivas-Crespo, Aurora, Navarrete-Sirvent, Carmen, Mantrana, Ana, Pera, Alejandra, Mena-Osuna, Rafael, Toledano-Fonseca, Marta, García-Ortíz, María Victoria, Villar, Carlos, Sánchez-Montero, Maria Teresa, Krueger, Janna, Medina-Fernández, Francisco Javier, De La Haba-Rodríguez, Juan, Gómez-España, Auxiliadora, Aranda, Enrique, Rudd, Christopher E., Rodríguez-Ariza, Antonio
Publikováno v:
In Biomedicine & Pharmacotherapy November 2023 167
Autor:
Jiménez-Fonseca, P., Sastre, J., García-Alfonso, P., Gómez-España, M.A., Salud, A., Gil, S., Rivera, F., Reina, J.J., Quintero, G., Valladares-Ayerbes, M., Safont, M.J., La Casta, A., Robles-Díaz, L., García-Paredes, B., López López, R., Guillot, M., Gallego, J., Alonso-Orduña, V., Diaz-Rubio, E., Aranda, E.
Publikováno v:
In Clinical Colorectal Cancer June 2023 22(2):222-230
Autor:
Toledano-Fonseca, M., Gómez-España, M.A., Élez, E., Grávalos, C., García-Alfonso, P., Rodríguez, R., Losa, F., Alés Díaz, I., Graña, B., Valladares-Ayerbes, M., García-Ortiz, M.V., Polo, E., Salgado, M., Rivera, F., Safont, M.J., Salud, A., Ruiz-Casado, A., Tabernero, J.M., Riesco, M.C., Rodríguez-Ariza, A., Aranda, E.
Publikováno v:
In Biomedicine & Pharmacotherapy March 2023 159
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Toledano-Fonseca, M.A. Gómez-España, E. Élez, C. Grávalos, P. García-Alfonso, R. Rodríguez, F. Losa, I. Alés Díaz, B. Graña, M. Valladares-Ayerbes, M.V. García-Ortiz, E. Polo, M. Salgado, F. Rivera, M.J. Safont, A. Salud, A. Ruiz-Casado, J.M. Tabernero, M.C. Riesco, A. Rodríguez-Ariza, E. Aranda
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 159, Iss , Pp 114272- (2023)
The benefit of adding the antiangiogenic drug aflibercept to FOLFIRI regime in metastatic colorectal cancer (CRC) patients resistant to or progressive on an oxaliplatin-based therapy has been previously demonstrated. However, the absence of validated
Externí odkaz:
https://doaj.org/article/9a89665eb0494d6e8b170dca3f0b8428
Autor:
Benavides, Manuel, Gómez-España, Auxiliadora, García-Alfonso, Pilar, González, Cristina García, Viéitez, Jose María, Rivera, Fernando, Safont, María José, Abad, Albert, Sastre, Javier, Valladares-Ayerbes, Manuel, Carrato, Alfredo, González-Flores, Encarnación, Robles, Luis, Salud, Antonieta, Alonso-Orduña, Vicente, Montagut, Clara, Asensio, Elena, Díaz-Rubio, Eduardo, Aranda, Enrique
Publikováno v:
In European Journal of Surgical Oncology May 2022 48(5):1123-1132
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ramón Salazar, Jaume Capdevila, Jose Luis Manzano, Carles Pericay, Mercedes Martínez-Villacampa, Carlos López, Ferrán Losa, María José Safont, Auxiliadora Gómez-España, Vicente Alonso-Orduña, Pilar Escudero, Javier Gallego, Beatriz García-Paredes, Amalia Palacios, Sebastiano Biondo, Cristina Grávalos, Enrique Aranda, on behalf of the Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD)
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Preoperative chemoradiotherapy with capecitabine is considered as a standard of care for locally advanced rectal cancer. The “Tratamiento de Tumores Digestivos” group (TTD) previously reported in a randomized Ph II study that
Externí odkaz:
https://doaj.org/article/a4aa7e2c60b44e39af5cbf4a269301f7